Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Finished Goods (2016 - 2019)

Prestige Consumer Healthcare has reported Finished Goods over the past 8 years, most recently at $102.6 million for Q1 2019.

  • Quarterly results put Finished Goods at $102.6 million for Q1 2019, down 2.51% from a year ago — trailing twelve months through Mar 2019 was $102.6 million (down 2.51% YoY), and the annual figure for FY2019 was $102.6 million, down 2.51%.
  • Finished Goods for Q1 2019 was $102.6 million at Prestige Consumer Healthcare, up from $99.6 million in the prior quarter.
  • Over the last five years, Finished Goods for PBH hit a ceiling of $105.3 million in Q1 2018 and a floor of $66.3 million in Q2 2015.
  • Median Finished Goods over the past 5 years was $87.9 million (2016), compared with a mean of $86.8 million.
  • Biggest five-year swings in Finished Goods: dropped 6.33% in 2015 and later grew 28.79% in 2016.
  • Prestige Consumer Healthcare's Finished Goods stood at $72.6 million in 2015, then increased by 28.12% to $93.0 million in 2016, then grew by 13.2% to $105.3 million in 2017, then decreased by 5.35% to $99.6 million in 2018, then rose by 3.02% to $102.6 million in 2019.
  • The last three reported values for Finished Goods were $102.6 million (Q1 2019), $99.6 million (Q3 2018), and $105.3 million (Q1 2018) per Business Quant data.